Lexaria Bioscience Corp. LEXX
3.28
(0.09)
(2.67%)
as of 25 Sep
- Market cap
- $7.1M
- P/E
- 0.0×
Follow LEXX
Growth Flags
show if company had growth for consecutive years
| Aug '25 | Aug '24 | Aug '23 | Aug '22 | Aug '21 | Aug '20 | Aug '19 | Aug '18 | Aug '17 | Aug '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
22.60 | 97.40 | 30.73 | 68.21 | 37.81 | 6.10 | 15.18 | 22.37 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(6.04) | (23.91) | (4.29) | (14.81) | (24.57) | (3.00) | (4.59) | (11.58) | (2.34) | (3.27) |
P/B ratio |
6.13 | 5.90 | 2.59 | 2.28 | 2.09 | 0.77 | 1.36 | 4.06 | 0.51 | 0.00 |
Price to Tangible BV |
6.95 | 6.33 | 3.13 | 2.44 | 2.15 | 0.88 | 1.52 | 4.32 | 0.52 | 0.00 |
EV/Sales |
20.06 | 83.66 | 24.97 | 44.29 | 21.63 | 2.14 | 9.12 | 18.36 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(1.36) | (7.83) | (0.96) | (2.32) | (3.92) | (0.26) | (0.67) | (3.16) | 0.00 | 0.00 |
EV/FCF |
(1.34) | (7.53) | (0.93) | (2.24) | (4.11) | (0.20) | (0.54) | (3.06) | 0.00 | 0.00 |
Quick Ratio |
1.56 | 6.10 | 5.99 | 32.80 | 78.89 | 7.20 | 8.79 | 45.94 | 27.94 | 0.52 |
Current Ratio |
2.32 | 7.18 | 8.04 | 35.97 | 81.17 | 8.53 | 9.86 | 52.39 | 30.29 | 1.18 |
Net Debt/EBITDA |
0.17 | 1.15 | 0.21 | 0.94 | 2.11 | 0.31 | 0.48 | 0.29 | 1.30 | (0.22) |
Debt/Assets |
0.00% | 0.00% | 5.32% | 0.64% | 0.44% | 2.36% | 0.00% | 0.32% | 0.00% | 66.43% |
Debt/Equity |
0.00 | 0.00 | 0.06 | 0.01 | 0.00 | 0.03 | 0.00 | 0.00 | 0.01 | 1.42 |
Asset Turnover |
0.11 | 0.08 | 0.04 | 0.02 | 0.09 | 0.11 | 0.09 | 0.36 | 0.22 | 0.02 |
Operating CF/Net income |
0.88 | 0.86 | 0.88 | 0.67 | 0.99 | 0.67 | 0.72 | 0.38 | 0.70 | 0.54 |
Capex/Depreciation |
(1.14) | (2.48) | (1.17) | (1.76) | 1.31 | (0.23) | (12.69) | (37.13) | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
| (231.96%) | (112.10%) | (129.26%) | (70.25%) | (51.81%) | (158.21%) | (170.46%) | (245.03%) | (114.25%) | (74.25%) | |
| (182.50%) | (96.98%) | (122.09%) | (68.90%) | (50.04%) | (142.97%) | (162.85%) | (543.56%) | (659.83%) | (70.90%) | |
ROIC |
(1,168.81%) | (325.87%) | (298.87%) | (271.82%) | (259.46%) | (209.81%) | (156.74%) | (568.66%) | 0.00% | 0.00% |
Return on Tangible Assets |
(540.28%) | (82.16%) | (311.79%) | (102.40%) | (31.81%) | (180.17%) | (186.84%) | (294.83%) | (69.10%) | (1,541.62%) |
Average Days of Receivables |
190.49 | 121.46 | 204.45 | 288.40 | 172.93 | 363.96 | 447.81 | 223.90 | 259.98 | 1,175.71 |
Research and Development Expense of Revenue |
1,167.13% | 508.42% | 1,621.00% | 721.50% | 174.75% | 122.97% | 249.64% | 113.75% | 85.22% | 22.11% |
Selling, General and Administrative Expense of Revenue |
615.55% | 829.64% | 1,353.67% | 1,942.01% | 687.88% | 1,263.37% | 381.22% | 112.88% | 2,882.23% | 2,941.28% |
Intangible Assets out of Total Assets |
0.07 | 0.06 | 0.15 | 0.06 | 0.03 | 0.10 | 0.10 | 0.06 | 0.00 | 0.10 |
Share Based Compensation of Revenue |
121.76% | 106.01% | 75.33% | 764.53% | 68.49% | 393.68% | 386.88% | 780.82% | 0.00% | 0.00% |
Graham Net Nets |
0.12 | 0.15 | 0.25 | 0.39 | 0.45 | 0.82 | 0.48 | 0.23 | 1.91 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(73.33%) | (12.87%) | (96.14%) | (42.21%) | (15.44%) | (220.66%) | (123.10%) | (68.19%) | (46.07%) | (46.07%) |
Free Cash Flow Yield |
(66.13%) | (11.41%) | (87.08%) | (29.03%) | (13.92%) | (171.78%) | (111.74%) | (26.86%) | 0.00% | 0.00% |
Revenue per Share |
0.59 | 0.56 | 0.51 | 0.65 | 2.47 | 1.70 | 1.29 | 2.75 | 0.03 | 0.02 |
Operating CF per Share |
(8.70) | (6.00) | (13.33) | (12.43) | (13.62) | (14.16) | (17.39) | (15.98) | (0.67) | (0.40) |
Capex per Share |
(0.08) | (0.23) | (0.38) | (0.46) | 0.66 | (0.18) | (4.45) | (0.54) | 0.00 | 0.00 |
Free Cash Flow per Share |
(8.79) | (6.23) | (13.71) | (12.89) | (12.96) | (14.34) | (21.84) | (16.52) | (0.67) | (0.40) |
Cash per Share |
1.64 | 7.94 | 3.35 | 15.70 | 40.12 | 7.10 | 7.81 | 11.02 | 1.29 | 0.06 |
Shareholders Equity per Share |
2.17 | 9.27 | 6.07 | 19.45 | 44.60 | 13.42 | 14.41 | 15.15 | 1.53 | 0.16 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.17 | 9.27 | 6.07 | 19.45 | 44.60 | 13.42 | 14.41 | 15.15 | 1.53 | 0.16 |
Free Cash Flow |
(10.55) | (5.15) | (6.05) | (5.06) | (3.80) | (2.65) | (3.77) | (2.60) | (1.31) | (0.66) |
Working Capital |
1.97 | 6.80 | 1.88 | 6.78 | 12.29 | 1.70 | 1.63 | 2.24 | 2.70 | 0.08 |
Capital Expenditures |
(0.10) | (0.19) | (0.17) | (0.18) | 0.19 | (0.03) | (0.77) | (0.09) | (0.01) | (0.02) |
Net Current Asset Value |
1.90 | 6.69 | 1.75 | 6.78 | 12.24 | 1.58 | 1.63 | 2.24 | 2.70 | 0.03 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.14 | 0.41 | 0.75 | 0.71 | (0.27) | 0.11 | 3.46 | 0.20 | 0.00 | 0.00 |
Net Profit Margin |
(1,686.05%) | (1,248.18%) | (2,946.46%) | (2,846.24%) | (557.22%) | (1,249.68%) | (1,868.10%) | (1,525.32%) | (2,939.15%) | (2,984.77%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.38 | 0.30 | 0.57 | 0.33 | 0.40 | 0.30 | 0.10 | 1.92 | 0.79 | 0.24 |
Cash ROIC |
(233.65%) | (36.68%) | (141.96%) | (37.53%) | (17.52%) | (80.32%) | (93.67%) | (60.95%) | (23.45%) | (90.16%) |
Accounts Receivable Turnover |
2.70 | 3.30 | 1.38 | 0.94 | 2.20 | 1.07 | 0.83 | 2.79 | 0.72 | 0.46 |
Accounts Payable Turnover |
0.00 | 0.01 | 0.16 | 0.56 | 1.82 | 0.89 | 0.27 | 0.74 | 0.51 | 0.75 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 2.11 | 2.39 | 0.81 | 0.21 | 0.33 | 0.31 | 0.46 |
Average Days of Payables |
197,775.93 | 81,090.83 | 2,779.79 | 769.65 | 219.67 | 319.10 | 2,174.06 | 518.53 | 381.38 | 711.04 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 195.21 | 61.63 | 429.26 | 2,030.61 | 1,263.02 | 786.15 | 1,064.19 |
Average Receivables |
0.26 | 0.14 | 0.16 | 0.27 | 0.33 | 0.29 | 0.27 | 0.16 | 0.09 | 0.09 |
Average Payables |
1.26 | 0.65 | 0.20 | 0.13 | 0.10 | 0.11 | 0.09 | 0.03 | 0.06 | 0.06 |
Average Inventory |
— | — | — | 0.03 | 0.07 | 0.12 | 0.11 | 0.08 | 0.10 | 0.10 |
Average Assets |
6.52 | 5.98 | 5.46 | 10.55 | 8.05 | 2.75 | 2.55 | 1.22 | 0.28 | 1.71 |
Average Common Equity |
5.13 | 5.17 | 5.16 | 10.35 | 7.77 | 2.49 | 2.44 | 2.70 | 1.64 | 1.64 |
Columns are period end dates